The global point of care (PoC) diagnostics market size is expected to reach USD 115.44 billion by 2032, expected to grow at a CAGR of 9.40% during the forecast period.
The Point of Care (POC) Diagnostics Market refers to the market for diagnostic devices and tests that are performed at or near the site of patient care. POC diagnostics enable immediate testing and rapid results, allowing healthcare professionals to make quicker decisions regarding patient treatment. This market includes a wide range of devices and tests used in various healthcare settings, such as hospitals, clinics, ambulatory care centers, home care, and emergency care environments.
Growth Drivers of the POC Diagnostics Market
- Rising Prevalence of Chronic Diseases
- The increasing incidence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders is fueling the demand for continuous monitoring and early detection, which POC diagnostic tests provide. These tests help in managing chronic conditions and preventing complications by enabling timely intervention.
- Aging Population
- The aging global population is contributing to the growing demand for healthcare services. Older adults are more likely to experience chronic health conditions, and the need for timely diagnostics and ongoing monitoring has led to a surge in the use of POC diagnostics in both clinical and home settings.
- Technological Advancements in Diagnostic Devices
- Advances in technology, such as miniaturization, automation, and integration of artificial intelligence (AI), have significantly improved the accuracy, speed, and usability of POC diagnostic devices. The development of mobile diagnostic platforms, wearable sensors, and compact test kits has expanded the scope and reach of POC diagnostics.
Some of the major players operating in the global market include:
- Abbott Laboratories
- AccuBioTech
- Becton, Dickinson and Company
- Chembio Diagnostic Systems
- Danaher Corporation
- EKF Diagnostics
- Instrumentation Laboratory Company
- Johnson & Johnson
- Nova Biomedical
- PTS Diagnostics
- Quidel Corporation
Download Free Sample PDF Copy of the Report:
Key Trends in the POC Diagnostics Market
- Integration of Artificial Intelligence and Data Analytics
- AI and machine learning are increasingly being integrated into POC diagnostic devices. These technologies enhance the accuracy and efficiency of tests by automating data analysis, interpreting complex results, and providing decision support to healthcare providers.
- Expansion of Wearable Diagnostic Devices
- Wearable devices for continuous health monitoring, such as smartwatches and fitness trackers, are evolving to incorporate diagnostic features. These devices can track vital signs, detect abnormalities, and offer early warnings about potential health issues, contributing to the growth of POC diagnostics.
- Regulatory Support and Approval for POC Devices
- Regulatory agencies such as the FDA and EMA are offering expedited approval processes for innovative POC diagnostic devices. This trend is helping companies bring new products to market faster and meet the increasing demand for efficient diagnostics in emergency and clinical settings.
Recent Developments
- In November 2022, LumiraDx Healthcare has launched its high-sensitivity C-Reactive Protein (CRP) point-of-care (POC) antigen test in India. This POC CRP test is designed to be used in various clinical settings and aims to contribute to the reduction of unnecessary antibiotic prescribing, which is a significant factor in the development of antimicrobial resistance (AMR).
- In January 2022, Roche has launched its Cobas Pulse System in certain countries where it has received the CE Mark certification. The Cobas Pulse System represents the latest advancement in Roche Diagnostics’ connected point-of-care solutions for professional blood glucose management.
𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
The research study includes segmental analysis that divides the market into distinct groups or segments based on common characteristics. With market segmentation, businesses can identify specific customer groups that are more likely to be interested in specific products or services. Also, it enables these businesses to focus their marketing efforts and resources more efficiently, leading to higher conversion rates and improved return on investment. Furthermore, segmentation analysis helps companies develop personalized products or services, which can result in increased customer loyalty and improved customer satisfaction.
Point of Care (PoC) Diagnostics, Product Outlook (Revenue – USD Billion, 2019 – 2032)
- Glucose Testing
- Hb1Ac Testing
- Coagulation
- Fertility
- Infectious Diseases
- HIV
- Clostridium Difficile
- HBV
- Pneumonia or Streptococcus Associated Infections
- Respiratory Syncytial Virus (RSV)
- HPV
- Influenza/Flu
- HCV
- MRSA
- TB and Drug-Resistant TB
- HSV
- Others
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug Abuse Testing
- Urinalysis
Point of Care (PoC) Diagnostics, Platform Outlook (Revenue – USD Billion, 2019 – 2032)
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular Diagnostics
- Immunoassays
Point of Care (PoC) Diagnostics, End-use Outlook (Revenue – USD Billion, 2019 – 2032)
- Clinics
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinic
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory
The Point of Care (POC) diagnostics market is growing rapidly, driven by technological advancements, an increasing demand for personalized healthcare, and the need for faster, cost-effective diagnostic solutions.